# IMVT (Immunovant, Inc.) - SEC EDGAR Financial Statements

> Immunovant, Inc. reported $761.0M in total assets and a net loss of $509.0M through March 31, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/IMVT
- Markdown: https://convexityos.com/fundamentals/IMVT.md
- SEC CIK: 0001764013
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:11 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001764013&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Mar 31, 2026 |
| Operating Income | FY 2026 | -- | Operating profit |
| Net Income | FY 2026 | -$509.0M | GAAP bottom line |
| Diluted EPS | FY 2026 | -$2.46 | Split-adjusted |
| Free Cash Flow | FY 2026 | -$407.3M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $722.3M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $456.7M | $360.9M | $212.9M | $160.3M | $101.8M | $68.60M | $47.93M | $25.73M |
| Total Operating Expenses | $532.9M | $438.2M | $282.7M | $218.3M | $156.0M | $108.1M | $66.08M | $28.43M |
| Interest Expense | -- | -- | -- | -- | -- | $0 | $625K | -- |
| Income Before Tax | -$505.4M | -$412.9M | -$258.8M | -$211.0M | -$156.8M | -$107.8M | -$66.29M | -$28.58M |
| Income Tax Expense | $215K | $891K | $567K | $9.0K | -$84K | -$358K | $97K | $19K |
| **Net Income** | -$505.6M | -$413.8M | -$259.3M | -$211.0M | -$156.7M | -$107.4M | -$66.39M | -$28.60M |
| Basic EPS | -$2.77 | -$2.73 | -$1.88 | -$1.71 | -$1.43 | -$1.22 | -$1.54 | -$1.29 |
| **Diluted EPS** | -$2.77 | -$2.73 | -$1.88 | -$1.71 | -$1.43 | -$1.22 | -$1.54 | -$1.29 |
| Basic Shares Outstanding | 182.4M | 151.6M | 138.1M | 123.1M | 109.7M | 87.8M | 43.2M | 22.2M |
| Diluted Shares Outstanding | 182.4M | 151.6M | 138.1M | 123.1M | 109.7M | 87.8M | 43.2M | 22.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $85.01M | $142.6M | $142.3M | $98.92M | $114.2M | $101.2M | $93.65M | $94.52M |
| Total Operating Expenses | $104.2M | $160.3M | $159.6M | $114.4M | $131.8M | $127.2M | $113.8M | $114.3M |
| Income Before Tax | -$97.25M | -$153.2M | -$150.7M | -$109.1M | -$125.9M | -$119.7M | -$105.9M | -$111.0M |
| Income Tax Expense | $0 | $0 | -$2.84M | $1.55M | $594K | $913K | $583K | $152K |
| **Net Income** | -$97.25M | -$153.2M | -$147.9M | -$110.6M | -$126.5M | -$120.6M | -$106.4M | -$111.1M |
| Basic EPS | -$0.47 | -$0.75 | -- | -$0.61 | -$0.73 | -$0.71 | -- | -$0.76 |
| **Diluted EPS** | -$0.47 | -$0.75 | -- | -$0.61 | -$0.73 | -$0.71 | -- | -$0.76 |
| Basic Shares Outstanding | 206.7M | 205.5M | -- | 181.5M | 173.6M | 170.9M | -- | 146.9M |
| Diluted Shares Outstanding | 206.7M | 205.5M | -- | 181.5M | 173.6M | 170.9M | -- | 146.9M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $902.1M | $714.0M | $635.4M | $376.5M | $493.8M | $400.1M | $100.6M | $6.99M |
| **Cash & Short-Term Investments** | $902.1M | $714.0M | $635.4M | $376.5M | $493.8M | $400.1M | $100.6M | $6.99M |
| Accounts Receivable, Net | $1.13M | $2.08M | $5.34M | $700K | $12.23M | $596K | -- | -- |
| **Total Current Assets** | $948.8M | $767.7M | $665.8M | $404.3M | $512.9M | $409.0M | $109.1M | $12.58M |
| Property, Plant & Equipment, Net | $443K | $844K | $462K | $333K | $330K | $201K | $65K | $54K |
| Other Non-Current Assets | $7.75M | $7.62M | $0 | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $8.20M | $8.56M | $595K | $1.50M | $2.63M | $3.48M | $311K | $1.25M |
| **Total Assets** | $957.0M | $776.2M | $666.4M | $405.8M | $515.6M | $412.5M | $109.4M | $13.83M |
| Accounts Payable | $7.54M | $17.66M | $7.16M | $1.35M | $18.63M | $2.43M | $1.19M | $206K |
| Other Current Liabilities | $175K | $273K | $15K | $350K | -- | -- | -- | -- |
| **Total Current Liabilities** | $104.4M | $68.78M | $48.61M | $43.30M | $44.52M | $18.77M | $15.32M | $300K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $47K | $1.22M | $2.24M | $0 | $6.19M |
| **Total Liabilities** | $104.4M | $68.78M | $48.61M | $43.34M | $45.74M | $21.01M | $15.32M | $6.49M |
| **Total Debt (incl. Leases)** | $72K | $98K | $138K | $1.22M | $2.36M | $3.42M | -- | -- |
| Common Stock | $20K | $16K | $14K | $13K | $12K | $10K | $5.0K | $4.0K |
| Retained Earnings | -$1.75B | -$1.24B | -$825.7M | -$566.3M | -$355.4M | -$198.7M | -$91.23M | -$24.84M |
| Accumulated Other Comp. Income | $730K | $1.46M | $1.91M | $852K | $404K | -$298K | -$16K | $346K |
| **Total Stockholders' Equity** | $852.6M | $707.4M | $617.8M | $362.5M | $469.8M | $391.5M | $94.07M | $7.34M |
| Total Equity | $852.6M | $707.4M | $617.8M | $362.5M | $469.8M | $391.5M | $94.07M | $7.34M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $722.3M | $797.8M | $902.1M | $994.5M | $521.9M | $598.9M | $714.0M | $374.7M |
| **Cash & Short-Term Investments** | $722.3M | $797.8M | $902.1M | $994.5M | $521.9M | $598.9M | $714.0M | $374.7M |
| Accounts Receivable, Net | $138K | $697K | $1.13M | $1.64M | $1.97M | $1.94M | $2.08M | $2.22M |
| **Total Current Assets** | $760.0M | $851.2M | $948.8M | $1.04B | $573.5M | $651.8M | $767.7M | $412.5M |
| Property, Plant & Equipment, Net | $262K | $351K | $443K | $531K | $632K | $737K | $844K | $752K |
| Other Non-Current Assets | $659K | $961K | $7.75M | $8.92M | $8.78M | $8.94M | $7.62M | $7.62M |
| **Total Non-Current Assets** | $921K | $1.31M | $8.20M | $9.45M | $9.41M | $9.68M | $8.56M | $8.39M |
| **Total Assets** | $761.0M | $852.5M | $957.0M | $1.05B | $583.0M | $661.4M | $776.2M | $420.9M |
| Accounts Payable | $6.79M | $10.14M | $7.54M | $8.62M | $6.92M | $7.84M | $17.66M | $19.82M |
| Other Current Liabilities | -- | -- | $175K | -- | -- | -- | $273K | -- |
| **Total Current Liabilities** | $104.0M | $117.1M | $104.4M | $66.26M | $63.25M | $52.90M | $68.78M | $68.31M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $104.0M | $117.1M | $104.4M | $66.26M | $63.25M | $52.90M | $68.78M | $68.31M |
| **Total Debt (incl. Leases)** | -- | -- | $72K | -- | -- | -- | $98K | $23K |
| Common Stock | $20K | $20K | $20K | $20K | $17K | $16K | $16K | $14K |
| Retained Earnings | -$2.00B | -$1.90B | -$1.75B | -$1.60B | -$1.49B | -$1.36B | -$1.24B | -$1.13B |
| Accumulated Other Comp. Income | $519K | $725K | $730K | $1.20M | $1.45M | $1.74M | $1.46M | $2.48M |
| **Total Stockholders' Equity** | $656.9M | $735.4M | $852.6M | $986.1M | $519.7M | $608.5M | $707.4M | $352.6M |
| Total Equity | $656.9M | $735.4M | $852.6M | $986.1M | $519.7M | $608.5M | $707.4M | $352.6M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$505.6M | -$413.8M | -$259.3M | -$211.0M | -$156.7M | -$107.4M | -$66.39M | -$28.60M |
| Depreciation & Amortization | $409K | $377K | $231K | $193K | $126K | $65K | $21K | $10K |
| Stock-Based Compensation | $55.72M | $49.49M | $41.12M | $32.30M | $34.24M | $18.82M | $6.96M | $1.31M |
| Change in Receivables | $986K | $3.23M | -$4.58M | $11.76M | -$11.63M | -$596K | -- | -- |
| Change in Payables | -$10.25M | $10.68M | $5.78M | -$17.12M | $16.25M | $1.25M | $967K | -$928K |
| **Operating Cash Flow** | -$407.3M | -$375.9M | -$214.2M | -$188.2M | -$106.1M | -$83.33M | -$53.36M | -$28.55M |
| Capital Expenditure | -$8.0K | -$759K | -$360K | -$197K | -$254K | -$210K | -$31K | -$52K |
| **Free Cash Flow** | -$407.3M | -$376.6M | -$214.6M | -$188.4M | -$106.4M | -$83.54M | -$53.39M | -$28.60M |
| **Investing Cash Flow** | -$8.0K | -$759K | -$360K | -$197K | -$254K | -$210K | -$31K | -$52K |
| Common Stock Issued | $544.2M | $450.0M | $472.7M | -- | -- | -- | -- | $14.91M |
| **Financing Cash Flow** | $595.8M | $454.5M | $472.4M | $70.89M | $200.1M | $383.1M | $147.0M | $35.58M |
| **Net Change in Cash** | $188.1M | $78.61M | $258.8M | -$117.3M | $93.67M | $299.6M | $93.59M | $6.99M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$97.25M | -$153.2M | -$147.9M | -$110.6M | -$126.5M | -$120.6M | -$106.4M | -$111.1M |
| Depreciation & Amortization | $89K | $92K | $96K | $101K | $105K | $107K | $109K | $99K |
| Stock-Based Compensation | $13.28M | $13.77M | $11.14M | $12.71M | $13.36M | $18.51M | $11.69M | $11.65M |
| Change in Receivables | $558K | $436K | $563K | $319K | -$25K | $129K | $85K | -$197K |
| Change in Payables | -$3.35M | $2.60M | -$1.35M | $1.56M | -$1.06M | -$9.40M | -$2.30M | -$260K |
| **Operating Cash Flow** | -$83.22M | -$124.4M | -$95.06M | -$92.33M | -$102.5M | -$117.4M | -$110.6M | -$100.4M |
| Capital Expenditure | -- | -- | -$8.0K | $0 | $0 | $0 | -$201K | -$180K |
| **Free Cash Flow** | -- | -- | -$95.07M | -$92.33M | -$102.5M | -$117.4M | -$110.8M | -$100.6M |
| **Investing Cash Flow** | -- | -- | -$8.0K | $0 | $0 | $0 | -$201K | -$180K |
| **Financing Cash Flow** | $7.88M | $20.10M | $3.64M | $564.6M | $24.59M | $2.92M | $450.6M | $2.46M |
| **Net Change in Cash** | -$75.52M | -$104.3M | -$92.42M | $472.7M | -$77.04M | -$115.1M | $339.3M | -$98.26M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -59.3% | -58.5% | -42.0% | -58.2% | -33.4% | -27.4% | -70.6% | -389.7% |
| Return on Assets (ROA) | -52.8% | -53.3% | -38.9% | -52.0% | -30.4% | -26.0% | -60.7% | -206.8% |
| Current Ratio | 9.09x | 11.16x | 13.70x | 9.34x | 11.52x | 21.79x | 7.12x | 41.87x |
| Quick Ratio | 8.65x | 10.41x | 13.18x | 8.71x | 11.37x | 21.35x | 6.57x | 23.25x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -77.5% | -73.2% | -59.3% | -47.1% | -89.4% | -73.5% | -58.5% | -108.5% |
| Return on Assets (ROA) | -66.9% | -63.1% | -52.8% | -44.1% | -79.7% | -67.6% | -53.3% | -90.9% |
| Current Ratio | 7.31x | 7.27x | 9.09x | 15.74x | 9.07x | 12.32x | 11.16x | 6.04x |
| Quick Ratio | 6.94x | 6.82x | 8.65x | 15.03x | 8.28x | 11.36x | 10.41x | 5.52x |
| Debt to Equity | -- | -- | 0.00x | -- | -- | -- | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
